Expand TNYA Menu
TNYA MENU

TNYA Latest Press Releases

-- March 5, 2026 --

Tenaya Therapeutics Enters into Research Collaboration with Alnylam Pharmaceuticals to Identify and Validate Novel Genetic Targets for Cardiovascular Disease Therapeutics Globe Newswire 8:30 AM

-- March 2, 2026 --

Tenaya Therapeutics to Participate in the Leerink Partners Global Healthcare Conference 2026 Globe Newswire 4:05 PM

-- January 9, 2026 --

Tenaya Therapeutics Announces 2026 Strategic Priorities and Anticipated Milestones Globe Newswire 8:30 AM

-- December 12, 2025 --

Tenaya Therapeutics Announces Pricing of Public Offering Globe Newswire 12:16 AM

-- December 11, 2025 --

Tenaya Therapeutics Announces Proposed Public Offering Globe Newswire 4:02 PM
Tenaya Therapeutics Announces Rapid Resolution and Lifting of Clinical Hold for MyPEAK-1 Phase 1b/2a Clinical Trial of TN-201 Gene Therapy Globe Newswire 4:01 PM
Tenaya Therapeutics Reports Positive Interim Data from Cohort 1 of RIDGE -1 Phase 1b/2 Clinical Trial of TN-401 Gene Therapy for Adults with PKP2-associated ARVC Globe Newswire 4:01 PM

-- November 10, 2025 --

Tenaya Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update Globe Newswire 7:00 AM

-- November 8, 2025 --

Tenaya Therapeutics Presents Promising Interim Clinical Data from MYPEAK -1 Phase 1b/2a Clinical Trial of TN-201 Gene Therapy for the Treatment of MYBPC3-Associated Hypertrophic Cardiomyopathy Globe Newswire 11:25 AM

-- November 4, 2025 --

Tenaya Therapeutics Announces New Clinical Data for TN-201 Gene Therapy will be Featured in Late-Breaking Presentation at the American Heart Association Scientific Sessions 2025 Globe Newswire 5:30 PM

-- October 9, 2025 --

Tenaya Therapeutics to Participate in H.C. Wainwright Genetic Medicines Virtual Conference Globe Newswire 4:05 PM
Market Data Delayed 15 Minutes